- Framework of problems / Rigourous
- No quality assessment undertaken or reported
- Methodologic Assessment of the Systematic Reviews of Ophthalmic Adverse Drug Reactions Published in Ophthalmology Journals: A Systematic Review
Ref ID | 236 |
First Author | A. Penedones |
Journal | OPHTHALMIC RESEARCH |
Year Of Publishing | 2018 |
URL | https://www.karger.com/Article/Pdf/489932 |
Keywords |
Harms Protocols Pharmacological Risk of bias Pre-specification Ophthalmology Low reporting quality |
Problem(s) |
No quality assessment undertaken or reported Lack of prespecification in eligibility criteria Reasons for excluding potentially eligible studies not provided No registered or published protocol |
Number of systematic reviews included | 21 |
Summary of Findings | Of the 21 systematic reviews reporting ophthalmic adverse drug reactions, there were weak areas of AMSTAR 2 quality. Only 14% reported an a priori protocol; the methodological quality was assessed in 57% systematic reviews; 71% of systematic reviews did not explain their selection of the study designs for inclusion in the review. The list of excluded articles and reasons of exclusion was not described in 67% of systematic reviews. |
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? | Not Applicable |
Are the methods of the article described in enough detail to replicate the study? | Yes |